Sfoglia per Autore
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature
2022 Gemelli, M; Carbone, M; Abbate, M; Mancin, M; Zucchini, N; Colonese, F; Invernizzi, P; Bidoli, P; Cortinovis, D
Novel cytotoxic chemotherapies in small cell lung carcinoma
2021 Cortinovis, D; Bidoli, P; Canova, S; Colonese, F; Gemelli, M; Lavitrano, M; Banna, G; Liu, S; Morabito, A
Trabectedin in Malignant Pleural Mesothelioma: Results From the Multicentre, Single Arm, Phase II ATREUS Study
2021 Cortinovis, D; Grosso, F; Carlucci, L; Zucali, P; Pasello, G; Tiseo, M; Sperandi, F; Hollander, L; Galli, F; Torri, V; Rulli, E; Canova, S; Maconi, A; Bidoli, P; Ceresoli, G; D'Incalci, M
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial
2021 Rosati, G; Lonardi, S; Galli, F; Di Bartolomeo, M; Ronzoni, M; Zampino, M; Banzi, M; Zaniboni, A; Pasini, F; Bozzarelli, S; Garattini, S; Ferrari, D; Montesarchio, V; Mambrini, A; Ciuffreda, L; Galli, F; Pusceddu, V; Carlomagno, C; Bidoli, P; Amoroso, D; Bochicchio, A; Frassineti, L; Corsi, D; Bilancia, D; Pastorino, A; De Stefano, A; Labianca, R; Bilancia, D; Rosati, G; Montesarchio, V; Iaffaioli, R; Nasti, G; Daniele, B; Zagonel, V; Pella, N; Aprile, G; Pasini, F; Marchetti, R; Romiti, A; Ferrari, D; Foa, P; Zaniboni, A; Mosconi, S; Sobrero, A; Bidoli, P; Cazzaniga, M; Beretta, G; Cortesi, E; Barni, S; Petrelli, F; Allione, P; D'Arco, A; Valmadre, G; Piazza, E; Veltri, E; Ramus, G; Giustini, L; Tumulo, S; Cascinu, S; Granetto, C; Testore, F; Giordano, M; Moroni, M; Di Seri, M; Nuzzo, A; Angelelli, L; Gori, S; Farina, G; Aglietta, M; Franchi, R; Comande, M; Giordani, P; Tonini, G; Bucci, E; Ballestrero, A; Benasso, M; Graiff, C; Bravi, S; Caffo, O; Silva, R; Frontini, L; Rota, S; Cozzi, L; Cantore, M; Maiello, E; Cinieri, S; Silvestris, N; Romito, S; Gebbia, V; Banzi, M; Santoro, A; Artioli, F; Mattioli, R; Contu, A; Di Costanzo, F; Leonardi, F; Cavanna, L; Passalacqua, R; Amoroso, D; Sozzi, P; D'Amico, M; Amadori, D; Frassineti, L; Turci, D; Ravaioli, A; Pasquini, E; Gambi, A; Faedi, M; Cruciani, G; Bajetta, E; Di Bartolomeo, M; Gianni, L; Ionta, M; Massidda, B; Scartozzi, M; Zampino, M; Bochicchio, A; Ciarlo, A; Di Leo, A; Frustaci, S; Rangoni, G; Arizzoia, A; Pavesi, L; Verusio, C; Pinotti, G; Iop, A; De Placido, S; Carlomagno, C; Adamo, V; Ficorella, C; Natale, D; Greco, E; Rulli, E; Galli, F; Poli, D; Porcu, L; Torri, V
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale
2021 Bani, M; Rossi, E; Cortinovis, D; Russo, S; Gallina, F; Hillen, M; Canova, S; Cicchiello, F; Longarini, R; Cazzaniga, M; Bidoli, P; Valsecchi, M; Strepparava, M
Anti PD-L1 antibody: is there a histologic-oriented efficacy? Focus on atezolizumab in squamous cell non-small cell lung cancer
2021 Gemelli, M; Bidoli, P; Colonese, F; Canova, S; Cortinovis, D
High Prevalence and Early Occurrence of Skeletal Complications in EGFR Mutated NSCLC Patients With Bone Metastases
2020 Lagana, M; Gurizzan, C; Roca, E; Cortinovis, D; Signorelli, D; Pagani, F; Bettini, A; Bonomi, L; Rinaldi, S; Berardi, R; Filetti, M; Giusti, R; Pilotto, S; Milella, M; Intagliata, S; Baggi, A; Cortellini, A; Soto Parra, H; Brighenti, M; Petrelli, F; Bennati, C; Bidoli, P; Garassino, M; Berruti, A
Molecular and immune biomarkers for cutaneous melanoma: Current status and future prospects
2020 Pilla, L; Alberti, A; Mauro, P; Gemelli, M; Cogliati, V; Cazzaniga, M; Bidoli, P; Maccalli, C
Final overall survival and safety update for durvalumab in third- or later-line advanced NSCLC: The phase II ATLANTIC study
2020 Garassino, M; Cho, B; Kim, J; Mazieres, J; Vansteenkiste, J; Lena, H; Jaime, J; Gray, J; Powderly, J; Chouaid, C; Bidoli, P; Wheatley-Price, P; Park, K; Soo, R; Poole, L; Wadsworth, C; Dennis, P; Rizvi, N
Aplastic anemia in a patient with advanced lung adenocarcinoma during first line osimertinib: A case report and literature review
2020 Sala, L; Mancin, M; Pastore, A; Seminati, D; Cortinovis, D; Bidoli, P; Alberti, A
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non–small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study
2020 Luciani, A; Marra, A; Toschi, L; Cortinovis, D; Fava, S; Filipazzi, V; Tuzi, A; Cerea, G; Rossi, S; Perfetti, V; Rossi, A; Giannetta, L; Sala, L; Finocchiaro, G; Pizzutilo, E; Carelli, S; Agustoni, F; Cergnul, M; Zonato, S; Siena, S; Bidoli, P; Ferrari, D
Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial
2020 Barni, S; Rosati, G; Lonardi, S; Pella, N; Banzi, M; Zampino, M; Dotti, K; Rimassa, L; Marchetti, P; Maiello, E; Artioli, F; Ferrari, D; Labianca, R; Bidoli, P; Zaniboni, A; Sobrero, A; Iaffaioli, V; De Placido, S; Frassineti, G; Ciarlo, A; Buonadonna, A; Silvestris, N; Piazza, E; Pavesi, L; Moroni, M; Clerico, M; Aglietta, M; Giordani, P; Galli, F; Galli, F; Petrelli, F
Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial
2020 Molina-Vila, M; Stahel, R; Dafni, U; Jordana-Ariza, N; Balada-Bel, A; Garzón-Ibáñez, M; García-Peláez, B; Mayo-de-Las-Casas, C; Felip, E; Fontecedro, A; Gautschi, O; Peters, S; Massutí, B; Palmero, R; Aix, S; Carcereny, E; Früh, M; Pless, M; Popat, S; Cuffe, S; Bidoli, P; Kammler, R; Roschitzki-Voser, H; Tsourti, Z; Karachaliou, N; Rosell, R
New and Emerging Systemic Therapeutic Options for Advanced Cholangiocarcinoma
2020 Massironi, S; Pilla, L; Elvevi, A; Longarini, R; Rossi, R; Bidoli, P; Invernizzi, P
Disseminated intravascular coagulation in advanced lung adenocarcinoma during first-line pembrolizumab
2020 Alberti, A; Mancin, M; Cortinovis, D; Bidoli, P; Sala, L
Peritoneal carcinomatosis in non-small-cell lung cancer: retrospective multicentric analysis and literature review
2019 Abbate, M; Cortinovis, D; Tiseo, M; Vavalà, T; Cerea, G; Toschi, L; Canova, S; Colonese, F; Bidoli, P
Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab
2019 De Giorgi, U; Procopio, G; Giannarelli, D; Sabbatini, R; Bearz, A; Buti, S; Basso, U; Mitterer, M; Ortega, C; Bidoli, P; Ferraù, F; Crinò, L; Frassoldati, A; Marchetti, P; Mini, E; Scoppola, A; Verusio, C; Fornarini, G; Cartenì, G; Caserta, C; Sternberg, C
Liquid biopsy testing can improve selection of advanced non-small-cell lung cancer patients to rechallenge with gefitinib
2019 Esposito Abate, R; Pasquale, R; Sacco, A; Piccirillo, M; Morabito, A; Bidoli, P; Finocchiaro, G; Chiari, R; Foltran, L; Buosi, R; Tiseo, M; Giannetta, L; Battiloro, C; Fasola, G; Romano, G; Ciuffreda, L; Frassoldati, A; de Marinis, F; Cappuzzo, F; Normanno, N
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib
2019 Sharma, G; Cortinovis, D; Agustoni, F; Arosio, G; Villa, M; Cordani, N; Bidoli, P; Bisson, W; Pagni, F; Piazza, R; Gambacorti-Passerini, C; Mologni, L
Phase II Study of Roniciclib in Combination with Cisplatin/Etoposide or Carboplatin/Etoposide as First-Line Therapy in Patients with Extensive-Disease Small Cell Lung Cancer
2019 Reck, M; Horn, L; Novello, S; Barlesi, F; Albert, I; Juhasz, E; Kowalski, D; Robinet, G; Cadranel, J; Bidoli, P; Chung, J; Fritsch, A; Drews, U; Wagner, A; Govindan, R
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile